Ameritas Investment Partners, Inc. - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$25,690
-14.4%
8,104
+34.2%
0.00%0.0%
Q2 2023$30,004
+0.6%
6,0370.0%0.00%0.0%
Q1 2023$29,823
-28.0%
6,0370.0%0.00%
-50.0%
Q4 2022$41,414
-36.3%
6,0370.0%0.00%
-33.3%
Q3 2022$65,000
-4.4%
6,0370.0%0.00%0.0%
Q2 2022$68,000
+38.8%
6,037
+13.2%
0.00%
+50.0%
Q1 2022$49,000
-38.8%
5,3320.0%0.00%
-33.3%
Q4 2021$80,000
-41.6%
5,3320.0%0.00%
-40.0%
Q3 2021$137,000
-1.4%
5,3320.0%0.01%0.0%
Q2 2021$139,000
-14.2%
5,332
+16.1%
0.01%
-16.7%
Q1 2021$162,000
+39.7%
4,5940.0%0.01%
+20.0%
Q4 2020$116,000
-32.9%
4,5940.0%0.01%
-37.5%
Q3 2020$173,000
-5.5%
4,594
+7.2%
0.01%
-11.1%
Q2 2020$183,000
+181.5%
4,285
+27.9%
0.01%
+125.0%
Q1 2020$65,000
-25.3%
3,3510.0%0.00%0.0%
Q4 2019$87,000
-4.4%
3,3510.0%0.00%0.0%
Q3 2019$91,000
+1.1%
3,3510.0%0.00%0.0%
Q2 2019$90,000
+76.5%
3,351
+90.1%
0.00%
+100.0%
Q1 2019$51,000
+8.5%
1,7630.0%0.00%
-33.3%
Q4 2018$47,0001,7630.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$16,381,0009.53%
Wildcat Capital Management, LLC 2,128,370$19,389,0004.96%
TPG GP A, LLC 18,716,306$170,506,0002.11%
Pier Capital, LLC 746,669$6,802,0000.87%
Coastal Bridge Advisors, LLC 401,929$3,662,0000.84%
HARBOR CAPITAL ADVISORS, INC. 92,755$845,0000.40%
Lombard Odier Asset Management (Switzerland) SA 501,219$4,566,0000.36%
Navalign, LLC 74,271$623,0000.26%
PDT Partners, LLC 241,592$2,201,0000.19%
GSA CAPITAL PARTNERS LLP 148,804$1,356,0000.18%
View complete list of ALLOGENE THERAPEUTICS INC shareholders